Literature DB >> 8943541

Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids.

A Akoum1, A Lemay, I Paradis, N Rheault, R Maheux.   

Abstract

Endometriosis is generally associated with an immunoinflammatory process that takes place in the peritoneal cavity of patients. Interleukin (IL)-6, a multifunctional cytokine involved in numerous immunological and proliferative processes, has been found at high concentrations in the peritoneal fluid of endometriosis patients. The purpose of this study was to investigate the ability of endometriotic cells to produce IL-y and to assess the regulation of its secretion by proinflammatory cytokines and sex steroids. Cultures of human endometriotic cells were exposed to different concentrations of cytokines and sex steroid hormones for varying periods of time. IL-6 secretion was measured using an enzyme-linked immunosorbent assay. Endometriotic cells spontaneously released IL-6 in culture. IL-1 beta and tumour necrosis factor (TNF)-alpha (0.1-100.0 ng/ ml) potentiated IL-y secretion in a time- and dose-dependent manner. Interferon-gamma (0.4-400 ng/ml) induced a dose-related increase in IL-6 secretion and showed a synergistic effect on that secretion in combination with TNF-alpha (10 ng/ ml). Either spontaneous or cytokine-induced IL-6 secretion was inhibited by progesterone (10(-8)-10(-5) M) and danazol (10(-6) M), whereas oestradiol (10(-8)-10(-5) M) had a limited inhibitory effect. The antiprogestin RU486 (10(-8)-10(-4) M) antagonized the inhibitory effects of progesterone and danazol, but showed agonist action when used alone. These findings indicate that endometriotic tissue may actively contribute to the biological changes observed in the peritoneal fluid of endometriosis patients. They also provide new insights into the mechanisms of action of progesterone and those of danazol and RU486 used in the treatment of endometriosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943541     DOI: 10.1093/oxfordjournals.humrep.a019088

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  12 in total

1.  Physiological and cytogenetic characterization of immortalized human endometriotic cells containing episomal simian virus 40 DNA.

Authors:  A Akoum; J Lavoie; R Drouin; C Jolicoeur; A Lemay; R Maheux; E W Khandjian
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Relationship between cytokines and the embryotoxicity of hydrosalpingeal fluid.

Authors:  Mohamed A Bedaiwy; Tommaso Falcone; Jeffrey M Goldberg; Marjan Attaran; Rakesh Sharma; Kurt Miller; David R Nelson; Ashok Agarwal
Journal:  J Assist Reprod Genet       Date:  2005-04       Impact factor: 3.412

3.  Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis.

Authors:  Yuechao Zhao; Ping Gong; Yiru Chen; Jerome C Nwachukwu; Sathish Srinivasan; CheMyong Ko; Milan K Bagchi; Robert N Taylor; Kenneth S Korach; Kendall W Nettles; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Sci Transl Med       Date:  2015-01-21       Impact factor: 17.956

4.  Outcome of IVF in patients with endometriosis in comparison with tubal-factor infertility.

Authors:  A Bergendal; S Naffah; C Nagy; A Bergqvist; P Sjöblom; T Hillensjö
Journal:  J Assist Reprod Genet       Date:  1998-10       Impact factor: 3.412

5.  Prospective assessment of midsecretory endometrial leukemia inhibitor factor expression versus ανβ3 testing in women with unexplained infertility.

Authors:  Jason M Franasiak; Kristin J Holoch; Lingwen Yuan; David P Schammel; Steven L Young; Bruce A Lessey
Journal:  Fertil Steril       Date:  2014-03-29       Impact factor: 7.329

6.  Circulating and peritoneal fluid interleukin-6 levels and gene expression in pelvic endometriosis.

Authors:  Vânia Teixeira De Andrade; Andréa Prestes Nácul; Betânia Rodrigues Dos Santos; Sheila Bünecker Lecke; Poli Mara Spritzer; Débora Martinho Morsch
Journal:  Exp Ther Med       Date:  2017-07-13       Impact factor: 2.447

7.  Enhanced inflammatory activity of endometriotic lesions from the rectovaginal septum.

Authors:  Dominic Bertschi; Brett D McKinnon; Jakob Evers; Nick A Bersinger; Michael D Mueller
Journal:  Mediators Inflamm       Date:  2013-12-28       Impact factor: 4.711

Review 8.  Potential involvement of the immune system in the development of endometriosis.

Authors:  Cleophas M Kyama; Sophie Debrock; Jason M Mwenda; Thomas M D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2003-12-02       Impact factor: 5.211

9.  Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis.

Authors:  Qunyan Sun; Ding Ding; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2016-04-09       Impact factor: 5.211

10.  A comparison between serum levels of interleukin-6 and CA125 in patients with endometriosis and normal women.

Authors:  Maryam Kashanian; Elaheh Sariri; Mansoureh Vahdat; Maryam Ahmari; Yousef Moradi; Narges Sheikhansari
Journal:  Med J Islam Repub Iran       Date:  2015-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.